It Takes a Village: Cancer Immunotherapy Toxicities Require Multidisciplinary Management
Immune checkpoint inhibitor (ICI) toxicities require early recognition, coordinated care, and tailored management across specialties to maintain patient safety and treatment efficacy, a panel of experts stressed at the 2026 National Comprehensive Cancer Network Annual Meeting.